Henneberger PK, Mirabelli MC, Kogevinas M, Anto JM, Plana E, Dahlman-Hoglund A. The occupational contribution to severe exacerbation of asthma. Eur Respir J. 2010 Oct;36(4):743-50.
Mauskopf JA, Baker CL, Monz BU, Juniper MD. Cost effectiveness of tiotropium for chronic obstructive pulmonary disease: a systematic review of the evidence. J Med Econ. 2010 Sep 1;13(3):403-17.
Olivieri M, Mirabelli MC, Plana E, Radon K, Anto JM, Bakke P. Healthy hire effect, job selection and inhalation exposure among young adults with asthma. Eur Respir J. 2010 Sep;36(3):517-23.
Woodward TC, Brown R, Sacco P, Zhang J. Budget impact model of tobramycin inhalation solution for treatment of pseudomonas aeruginosa in cystic fibrosis patients. J Med Econ. 2010;13(3):492-9. doi: 10.3111/13696998.2010.505863
Jacquemin B, Sunyer J, Forsberg B, Aguilera I, Buoso L, Briggs D, de Marco R, Garcia-Esteban R, Henrich J, Jarvis D, Maldonado JA, Payo F, Rage E, Vienneau D, Kunzli N. Association between modelled traffic-related air pollution and asthma score in the ECRHS. Eur Respir J. 2009 Oct;34(4):834-42. doi: 10.1183/09031936.00138208
Blanc PD, Menezes AM, Plana E, Mannino DM, Hallal PC, Toren K. Occupational exposures and COPD: an ecological analysis of international data. Eur Respir J. 2009 Feb;33(2):298-304.
Mauskopf JA, Boye KS, Schmitt C, McCollam P, Birt J, Juniper MD, Bakhai A. Adherence to guidelines for sensitivity analysis: cost-effectiveness analyses of dual oral antiplatelet therapy. J Med Econ. 2009 Jan 1;12(2):141-53.
Sunyer J, Pistelli R, Plana E, Andreani M, Baldari F, Kolz M. Systemic inflammation, genetic susceptibility and lung function. Eur Respir J. 2008 Jul;32(1):92-7.
Ellison-Loschmann L, Sunyer J, Plana E, Pearce N, Zock JP, Jarvis D. Socioeconomic status, asthma and chronic bronchitis in a large community-based study. Eur Respir J. 2007 May;29(5):897-905.
Brodersen J, Meads DM, Kreiner S, Thorsen H, Doward LC, McKenna SP. Methodological aspects of differential item functioning in the Rasch model. J Med Econ. 2007;10:309-22.
Alexeyeva I, Mauskopf J, Earnshaw SR, Stauffer VL, Gibson JP, Ascher-Svanum H. Comparing olanzapine and ziprasidone in the treatment of schizophrenia: a case study in modeling. J Med Econ. 2001 Jan 1;4:179-92.
Beard SM, Gaffney L, Backhouse ME. An economic evaluation of ramipril in the treatment of patients at high risk for cardiovascular events due to diabetes mellitus. J Med Econ. 2001 Jan 1;4:199-205.